* Nephros Inc NEPH.OQ NEPH.O is expected to show a rise
in
quarterly revenue when it reports results on May 10.
* The South Orange New Jersey-based company is expected to
report
a 68.2% increase in revenue to $3.679 million from $2.19
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. The company's guidance on April 4 2023,
for the period ended March 31, was for revenue of $3.700
million.
* Refinitiv's mean analyst estimate for Nephros Inc is for
a loss
of 2 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Nephros Inc
is
$3, above its last closing price of $1.49.
This summary was machine generated May 8 at 23:34 GMT. All
figures in US dollars unless otherwise stated